Turk, V. et al. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim. Biophys. Acta Proteins Proteom. 1824, 68–88 (2012).

Article  CAS  Google Scholar 

Olson, O. C. & Joyce, J. A. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat. Rev. Cancer 15, 712–729 (2015).

Article  CAS  PubMed  Google Scholar 

Vidak, E., Javoršek, U., Vizovišek, M. & Turk, B. Cysteine cathepsins and their extracellular roles: shaping the microenvironment. Cells 8, 264 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Novinec, M. & Lenarčič, B. Papain-like peptidases: structure, function, and evolution. Biomol. Concepts 4, 287–308 (2013).

Article  CAS  PubMed  Google Scholar 

McClung, M. R. et al. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. Lancet Diabetes Endocrinol. 7, 899–911 (2019).

Article  CAS  PubMed  Google Scholar 

Smyth, P., Sasiwachirangkul, J., Williams, R. & Scott, C. J.Cathepsin S (CTSS) activity in health and disease—a treasure trove of untapped clinical potential. Mol. Aspects Med. 88, 101106 (2022).

Article  CAS  PubMed  Google Scholar 

Costa, A. G., Cusano, N. E., Silva, B. C., Cremers, S. & Bilezikian, J. P. Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat. Rev. Rheumatol. 7, 447–456 (2011).

Article  CAS  PubMed  Google Scholar 

McGlinchey, R. P. & Lee, J. C. Cysteine cathepsins are essential in lysosomal degradation of α-synuclein. Proc. Natl Acad. Sci. USA 112, 9322–9327 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fonović, M. & Turk, B. Cysteine cathepsins and extracellular matrix degradation. Biochim. Biophys. Acta Gen. Subj. 1840, 2560–2570 (2014).

Article  Google Scholar 

Dheilly, E. et al. Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma. Cancer Cell 37, 674–689 (2020).

Article  CAS  PubMed  Google Scholar 

Bararia, D. et al. Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma. Cell Rep. 31, 107522 (2020).

Article  CAS  PubMed  Google Scholar 

Rao, J. S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3, 489–501 (2003).

Article  CAS  PubMed  Google Scholar 

Lah, T. T. & Kos, J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol. Chem. 379, 125–130 (1998).

CAS  PubMed  Google Scholar 

Sevenich, L. et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat. Cell Biol. 16, 876–888 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gocheva, V. et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543–556 (2006).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gopinathan, A. et al. Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice. Gut 61, 877–884 (2012).

Article  CAS  PubMed  Google Scholar 

Shi, G. P. et al. Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J. Biol. Chem. 269, 11530–11536 (1994).

Article  CAS  PubMed  Google Scholar 

Riese, R. J. et al. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4, 357–366 (1996).

Article  CAS  PubMed  Google Scholar 

Victor, B. C., Anbalagan, A., Mohamed, M. M., Sloane, B. F. & Cavallo-Medved, D. Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion. Breast Cancer Res. 13, R115 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heidtmann, H.-H., Salge, U., Abrahamson, M., Ben, M. & Kastelic, L.Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines. Clin. Exp. Metastasis 15, 368–381 (1997).

Article  CAS  PubMed  Google Scholar 

Niedergethmann, M. et al. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma. Pancreas 29, 204–211 (2004).

Article  CAS  PubMed  Google Scholar 

Nouh, M. A. et al. Cathepsin B: a potential prognostic marker for inflammatory breast cancer. J. Transl. Med. 9, 1 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujise, N. et al. Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study. Lung Cancer 27, 19–26 (2000).

Article  CAS  PubMed  Google Scholar 

Sudhan, D. R., Pampo, C., Rice, L. & Siemann, D. W. Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model. Int. J. Cancer 138, 2665–2677 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Gall, C. et al. A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. Cancer Res. 67, 9894–9902 (2007).

Article  PubMed  Google Scholar 

Podgorski, I., Linebaugh, B. E. & Sloane, B. F. Cathepsin K in the bone microenvironment: link between obesity and prostate cancer? Biochem. Soc. Trans. 35, 701–703 (2007).

Article  CAS  PubMed  Google Scholar 

Choe, Y. et al. Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J. Biol. Chem. 281, 12824–12832 (2006).

Article  CAS  PubMed  Google Scholar 

Biniossek, M. L., Nägler, D. K., Becker-Pauly, C. & Schilling, O. Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S. J. Proteome Res. 10, 5363–5373 (2011).

Article  CAS  PubMed  Google Scholar 

Baugh, M. et al. Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity. J. Autoimmun. 36, 201–209 (2011).

Article  CAS  PubMed  Google Scholar 

Saegusa, K. et al. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J. Clin. Invest. 110, 361–369 (2002).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee-Dutra, A., Wiener, D. K. & Sun, S. Cathepsin S inhibitors: 2004–2010. Expert Opin. Ther. Pat. 21, 311–337 (2011).

Article  CAS  PubMed  Google Scholar 

Theron, M. et al. Pharmacodynamic monitoring of RO5459072, a small molecule inhibitor of cathepsin S. Front. Immunol. 8, 806 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Payne, C. D. et al. Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects: PK/PD and safety and tolerability of cathepsin S inhibitor. Br. J. Clin. Pharmacol. 78, 1334–1342 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kramer, L., Turk, D. & Turk, B. The future of cysteine cathepsins in disease management. Trends Pharmacol. Sci. 38, 873–898 (2017).

Article  CAS  PubMed  Google Scholar 

Gauthier, J. Y. et al. The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg. Med. Chem. Lett. 18, 923–928 (2008).

Article  CAS  PubMed  Google Scholar 

Stoch, S. A. et al. Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies. Clin. Pharmacol. Ther. 86, 175–182 (2009).

Article  CAS  PubMed  Google Scholar 

Bone, H. G. et al. Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density. J. Bone Miner. Res. 25, 937–947 (2010).

Article  PubMed